The 32-year-old founded Toms Shoes based on the simple idea that for every pair of his canvas shoes you buy, a pair is given to a child in need. To date, he’s given away 140,000 pairs of shoes ...

For those who don't know, Toms — it's short for "tomorrow" — is a company that promises if you buy a pair of its shoes, it will give a pair to a poor child somewhere in the world. And on Oscar ...

Last July, I wrote the below piece about the flaws in the “buy one give one” model pursued by companies like TOMS Shoes. So I was excited to see this clip from new TV show Adam Ruins ...

Mycoskie, the founder of TOMS Shoes is on a mission, covering soles to save lives. "For me, it's much bigger than the shoes," he told "Good Morning America." "When they are just realizing that we ...

TOMS Shoes and its founder and chief shoe giver Blake Mycoskie in many ways define 21st century social entrepreneurship and corporate responsibility. The young, prominent, sustainable, and ...

In the 2½ years since its inception, TOMS Shoes has distributed 150,000 pairs of shoes to impoverished children in Argentina, Ethiopia, South Africa and the U.S. via a series of "shoe drops." ...

“It’s my final days here in Costa Rica,” says the 46-year-old Mycoskie, founder of Toms shoes, which was famous for its buy-one-give-one business model. He’s been living in Santa ...

LOS ANGELES - Toms Shoes founder Blake Mycoskie spends much of his time traveling on shoe drops in South America and Africa and giving speeches about his One for One business model (for every pair ...

Toms collaborated with celebrity stylist Jamie Mizrahi on a limited-edition collection of Alpargata slip-on sneakers. The shoes are available in various colors and made with water-repellant suede.

The “Flash Sale” also has big savings on TOMS shoes for kids so you can stock up for the season. But like most Nordstrom Rack sale’s events the deals are going fast with popular styles ...

Blake Mycoskie, the founder of Toms Shoes, announced earlier this year that he’d give $100 million to support research into the medical and mental health potential of psychedelic drugs.